MarketInOut Stock Screener Log In | Sign Up
 

Arcutis Biotherapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/16/2026 16:00
Arcutis Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,279.3 mln
Float110 mln
Earnings Date10/29/2026

EPS

0.22
Overpriced

P / E

131
Highly speculative

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.03
Caution advised

1-Year Forecast

37.00
Strong upside

Relative Strength

97 / 100
Top performer

Business Description

Arcutis Biotherapeutics is a California-based company founded in 2016 that researches and brings to market new medicines for skin conditions. Its flagship product, ZORYVE, is available as both a cream and a foam to treat conditions such as plaque psoriasis, atopic dermatitis, and seborrheic dermatitis. The company is also working on an experimental treatment called ARQ-234, which targets the immune system to address skin disease in a novel way.

Key Fundamentals

EPS0.22
P/E131
ROE15.90
RPS3.60
ROIC35.04
ROA6.77
Interest Cover2.47
EBITDA, mln46.09
EV / EBITDA75.23
EV / EBIT80.37
Revenue, mln464
EV / Revenue7.47

Quote Details

Last 28.82
Change -0.28 (-0.96%)
Open 29.18
Volume 1,731,947
Turnover 49,914,712
Average Volume 2,938,578

Financial Ratios

Pre-Tax Profit Margin6
Leverage Ratio2.21
Current Ratio2.92
Price / Book15.02
Price / Tangible Book16.02
Price / Cash Flow86.63
Price / Free Cash Flow91.46
Debt / Equity0.52
Price / Sales7.62

Financial Strength

Altman Z-Score6.27
Piotroski F-Score 7 / 9
Beneish M-Score-2.03
Price to Graham Number9.54
1-Year Target Price37.00
Short Ratio6.49
Short % of Float18.40

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.43% 97 / 100   
1 Month 8.92% 95 / 100   
2 Months 6.27% 86 / 100   
6 Months 17.49% 89 / 100   
1 Year 33.24% 88 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us